Ledger.Open graph →
SEC Form D · filed September 4, 2025

PharmaCyte Biotech, Inc

Offering
$7.0M
Sold
$7.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
LAS VEGAS, NV
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Michael M. Abecassis · Laguna Hills, CADirectorJoshua N. Silverman · New York, NYExec · DirectorRobert M. Weinstein · LAS VEGAS, NVDirectorJonathan L. Schechter · New York, NYDirectorCarlos N. Trujillo · LAS VEGAS, NVExecWalker R. Wayne · LAS VEGAS, NVDirectorRobert M. Weinstein · LAS VEGAS, NVDirectorJonathan L. Schechter · New York, NYDirectorMichael M. Abecassis · Laguna Hills, CADirectorCarlos N. Trujillo · LAS VEGAS, NVExecJoshua N. Silverman · New York, NYExec · DirectorWalker R. Wayne · LAS VEGAS, NVDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗